Published Date: 26 Apr 2023
According to researchers from the Karolinska Institutet, patients with Crohn's disease and IBD have an elevated risk of developing lymphoma, and this risk has grown over the past few years.
Read Full News1.
Study: For predicting breast cancer, AI performs better than traditional risk models.
2.
When does a melanoma metastasize? Implications for management
3.
New drug combination shows good results in patients with HPV-negative head and neck cancer
4.
Researchers identify potential new therapeutic targets for treating T-cell lymphoma and natural killer cell tumors.
5.
Exercise could ease symptoms for people with chronic lymphocytic leukemia, support and guidance are lacking: Study
1.
Mechanisms, Efficacy, and Survival Outcomes in AML, Squamous Cell Carcinoma, & Non-Hodgkin Lymphoma
2.
Improving TIVAP Use: Review of Standardization and Optimization Practices
3.
Therapeutic Innovations Through Germline Predisposition in Acute Leukemias and Myeloid Neoplasms
4.
What You Need to Know About Correcting Calcium Levels in Patients with Low Albumin
5.
The Precision Revolution: Bispecific Antibodies and Antibody-Drug Conjugates Reshaping the Oncology Landscape
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Virtual Case Study on Deep Vein Thrombosis (DVT) - An Initiative by Hidoc Dr.
2.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part V
3.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion IV
4.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I
5.
Efficient Management of First line ALK-rearranged NSCLC - Part VII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation